-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OwD0vk1H80f828jylPUdZE/sNpGeh8jibIE4N7v1i52XnK11iWIfPvowUPSWh9oc zdhGfE54BpGLQO3vAiZ7mA== 0001181431-11-012345.txt : 20110223 0001181431-11-012345.hdr.sgml : 20110223 20110223162428 ACCESSION NUMBER: 0001181431-11-012345 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20110221 FILED AS OF DATE: 20110223 DATE AS OF CHANGE: 20110223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FERRARI LOUIS CENTRAL INDEX KEY: 0001513697 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 11632512 MAIL ADDRESS: STREET 1: 765 WARREN STREET CITY: WARRREN STREET STATE: NJ ZIP: 07090 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd302519.xml LOUIS FERRARI FORM 4 X0303 4 2011-02-21 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001513697 FERRARI LOUIS SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER, 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 SVP, North American Commerical Common Stock, $.01 par value per share 2011-02-21 4 A 0 40000 9.98 A 40000 D Option to Purchase Common Stock, $.01 par value 9.98 2011-02-21 4 A 0 100000 9.98 D 2011-02-21 2021-02-21 Common Stock, $.01 par value per share 100000 100000 D The right to receive these shares is pursuant to a restricted stock grant that vests as follows: 10,000 on February 21, 2012, and 2,500 shares at the end of each successive three-month period until February 21, 2015, provided that the grantee remains employed by the Company on these dates. These options will become exercisable as follows: 10,000 on February 21, 2012, and 7,500 shares at the end of each successive three-month period until February 21, 2015, provided the optionee remains employed by the Company on these dates. /s/ Irina Azer Ishak for Louis Ferrari 2011-02-23 EX-24.1 2 rrd271207_306177.htm POA LOUIS FERRARI rrd271207_306177.html 
POWER OF ATTORNEY

Know all by these present that the undersigned hereby constitutes and appoints Philip K. Yachmetz and Irina Azer Ishak with full power of substitution, the undersigned's true and lawful attorney-in-fact to:

(1)	execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or employee of Savient Pharmaceuticals, Inc. (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2)	do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3)	take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

The undersigned hereby revokes and withdraws any previously executed powers of attorney with respect to the completion, execution and filing of Forms 3, 4 and 5 relating to the undersigned's holdings of and transactions in securities issued by the Company.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this
21 day of February, 2011.

 	/s/ Louis Ferrari
 	Signature

 	Louis Ferrari
 	Print Name
-----END PRIVACY-ENHANCED MESSAGE-----